SciELO - Scientific Electronic Library Online

 
vol.35 número2Medición de monóxido de carbono en la unidad de cesación de tabaquismo: lecciones aprendidasSeguridad de los medicamentos gastrointestinales en el embarazo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Links relacionados

Compartir


Archivos de Medicina Interna

versión impresa ISSN 0250-3816versión On-line ISSN 1688-423X

Resumen

PARMA, Gabriel; LLUBERAS, Natalia; CASTILLO, Cecilia  y  ORMAECHEA, Gabriela. Chemotherapy agents and cardiotoxicity: a current and user-friendly approach for the clinician, a developing discipline. Arch. Med Int [online]. 2013, vol.35, n.2, pp.38-47. ISSN 0250-3816.

Abstract: Arch Med Interna 2013 - 35(2):37-47 Chemotherapy-induced cardiotoxicity is a frequent and expected adverse effect. In that regard, a new branch of medicine (cardio-oncology) has been created with the key objective of preventing such effects. The form of expression of this phenomenon is varied, and may manifest itself as heart failure, hypertension, acute coronary events and/or rhythm disorders. The key for prevention lies on the individualization of each patient’s cardiotoxic risk (based on well-recognized factors such as age, sex, history of irradiation of the mediastinum, type of drug, accumulated dosage, pre-existing associated heart disease) and the cardiotoxic potential of each chemotherapy agent. In that regard, decision trees have been developed based on the monitoring of patients and the early and timely start of therapy of each effect, preventing further damage in each patient.

Palabras clave : Cardiotoxicity; Chemotherapy agents; Heart failure; Myocardial ischaemia; Arterial hypertension; Rhythm disorders.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons